Decrease of Neuropsychiatric Side Effects After Switching From Atripla to Eviplera

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The aim of this prospective, open label study is to check for differences in neuropsychiatric and neurocognitive measurements among patients that will be switched from Atripla to Eviplera among 40 patients.
Epistemonikos ID: d0bdd983f583c79d6647ca8b01b526e09cd63bed
First added on: May 12, 2024